The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

Artificial intelligence (AI) is emerging as a tool that can improve patient outcomes and provider care efficiency, says Douglas Flora, MD, FACCC, of St. Elizabeth Healthcare.

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

In essence, the future of AI is inextricably linked to advancements in data management, making it an indispensable enabler of ...

In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...

Modern AI technology is data-hungry. In many areas, data is scarce. For example, in our work in early oncology clinical trials, we only have data on about 20 patients, so we tend to use theory-based ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...

Hyperscience, a market leader in hyperautomation and a provider of enterprise AI infrastructure software, today announced that DISA Global Solutions, a leading tech-powered provider of workplace ...

Maharashtra plans to introduce drug testing kits for drivers as road accidents claim over 40 lives daily. The state will ...